SN

Subburaj Nithya

Active Director Director DIN 09498492
DIN 09498492 First appointment Feb 2022 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Subburaj Nithya

Data last updated:

Subburaj Nithya is a Director at Mediyogs Healthcare India Private Limited (since 2022). The company operates in Manufacturing. Mediyogs Healthcare India Private Limited reported revenue of ₹2.06 Cr (FY 2025).

DIN 09498492
Primary Designation Director
Industry Manufacturing
First Appointment 09 Feb 2022
Oldest Company Age 4 yrs
Largest company Mediyogs Healthcare India Private Limited · ₹2.06 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Feb 20222022₹2.06 Cr (FY 2025)Active

Board colleagues of Subburaj Nithya

Directorship timeline

Open interactive timeline →
Mediyogs Healthcare India Private Limited
Premium access

Shareholding and investment profile for Subburaj Nithya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subburaj Nithya

Subburaj Nithya currently holds 1 directorship: Mediyogs Healthcare India Private Limited (Director, since 09 Feb 2022, revenue ₹2.06 Cr (FY 2025)).

Subburaj Nithya was first appointed on 09 Feb 2022 as Director at Mediyogs Healthcare India Private Limited.

The current boards of Subburaj Nithya's companies include Venkatraman Rajukannu (Mediyogs Healthcare India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available